Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Oligodendroglioma

• Study of Olutasidenib and Temozolomide in HGG
• Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
• A Study of Temodar With PCI-24781 for Patients With Recurrent Glioma
• Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma
• Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma
• A Phase 2 Trial of All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
• A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
• PARP Inhibition for Gliomas (PI-4G or π4g)
• Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular Analysis
• A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
• Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
• Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
• INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
• Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
• Pediatric Long-Term Follow-up and Rollover Study
• Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
• Abemaciclib in Patients With Oligodendroglioma
• Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
• Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
• SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
• Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
• A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
• Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
• Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
• Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
• RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
• Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
• First in Patient Study for PF-06840003 in Malignant Gliomas
• Expanded Access to ANG1005 for Individual Patients
• Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG
• Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
• Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
• Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
• Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
• Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
• A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
• Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
• Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
• 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
• Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
• Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
• Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
• Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
• Everolimus With and Without Temozolomide in Adult Low Grade Glioma
• Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
• 3T MRI Biomarkers of Glioma Treatment Response
• Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
• p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
• Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
• Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
• Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
• Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
• Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
• Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
• Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
• Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
• Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
• Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
• Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
• Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
• Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
• BIBF 1120 for Recurrent High-Grade Gliomas
• High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
• Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
• AZD8055 for Adults With Recurrent Gliomas
• RO4929097 in Treating Patients With Recurrent Invasive Gliomas
• Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
• Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
• RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
• A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
• Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
• A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
• Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
• Cellular Immunotherapy Study for Brain Cancer
• Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
• RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
• Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
• Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
• Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
• Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
• Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
• A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
• Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
• ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
• Treatment Strategy for Low-grade Gliomas
• Sorafenib in Newly Diagnosed High Grade Glioma
• Everolimus in Treating Patients With Recurrent Low-Grade Glioma
• Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
• Everolimus in Treating Patients With Recurrent Low-Grade Glioma
• Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
• A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
• Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
• A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
• Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
• Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
• Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
• Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
• Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
• Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
• Sunitinib in Treating Patients With Recurrent Malignant Gliomas
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
• Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
• Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
• The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
• A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
• Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
• Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
• Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
• AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
• Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
• Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
• Prolonged Daily Temozolomide for Low-Grade Glioma
• Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
• Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
• Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
• Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
• Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
• FR901228 in Treating Patients With Recurrent High-Grade Gliomas
• A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
• Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
• Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
• Cilengitide in Treating Children With Refractory Primary Brain Tumors
• Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
• Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
• Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
• Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
• Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
• Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
• Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
• Bortezomib in Treating Patients With Recurrent Glioma
• Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
• Irinotecan in Treating Children With Refractory Solid Tumors
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
• Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
• Topotecan in Treating Patients With Recurrent Brain Tumors
• Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
• Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma